HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$949M |
| 2 |
Apple
AAPL
|
$877M |
| 3 |
Microsoft
MSFT
|
$381M |
| 4 |
Equitable Holdings
EQH
|
$242M |
| 5 |
Broadcom
AVGO
|
$228M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$129M |
| 2 |
Citigroup
C
|
$119M |
| 3 |
Crown Holdings
CCK
|
$98.3M |
| 4 |
Elevance Health
ELV
|
$95.2M |
| 5 |
iShares MSCI South Korea ETF
EWY
|
$89.7M |
Sector Composition
| 1 | Technology | 28.28% |
| 2 | Financials | 13.39% |
| 3 | Healthcare | 11.82% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Communication Services | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MREO
2076
Mereo BioPharma
MREO
$282M
| $134K | ﹤0.01% |
58,217
| – | – |
|
2077
Alignment Healthcare
ALHC
$3.14B
| $134K | ﹤0.01% |
15,083
-14,375
| -49% | -$128K |
|
2078
ZIM Integrated Shipping Services
ZIM
$1.62B
| $134K | ﹤0.01% |
13,802
-41,977
| -75% | -$406K |
|
2079
Gambling.com
GAMB
$295M
| $133K | ﹤0.01% |
13,548
-2,733
| -17% | -$26.8K |
|
2080
Compass
COMP
$5.07B
| $132K | ﹤0.01% |
34,861
-10,542
| -23% | -$40.1K |
|
2081
Pediatrix Medical
MD
$1.49B
| $132K | ﹤0.01% |
+14,242
| New | +$132K |
|
2082
Entravision Communication
EVC
$226M
| $131K | ﹤0.01% |
31,089
+5,996
| +24% | +$25.2K |
|
2083
Marqeta
MQ
$2.76B
| $129K | ﹤0.01% |
18,494
+3,745
| +25% | +$26.2K |
|
|
INFN
2084
DELISTED
Infinera Corporation Common Stock
INFN
| $129K | ﹤0.01% |
27,028
+3,686
| +16% | +$17.6K |
|
2085
Information Services Group
III
$253M
| $129K | ﹤0.01% |
26,777
| – | – |
|
2086
Fortuna Silver Mines
FSM
$2.35B
| $128K | ﹤0.01% |
33,051
| – | – |
|
2087
Treace Medical Concepts
TMCI
$453M
| $128K | ﹤0.01% |
+10,127
| New | +$128K |
|
2088
Ooma
OOMA
$346M
| $128K | ﹤0.01% |
11,938
-10,004
| -46% | -$107K |
|
|
CTEV
2089
Claritev Corporation
CTEV
$1.15B
| $127K | ﹤0.01% |
2,148
+873
| +68% | +$51.7K |
|
2090
BioCryst Pharmaceuticals
BCRX
$1.74B
| $127K | ﹤0.01% |
21,035
+2,160
| +11% | +$13K |
|
2091
MaxCyte
MXCT
$150M
| $124K | ﹤0.01% |
27,535
-5,046
| -15% | -$22.7K |
|
2092
Kodiak Sciences
KOD
$556M
| $124K | ﹤0.01% |
40,821
+26
| +0.1% | +$79 |
|
2093
Sandstorm Gold
SAND
$3.37B
| $124K | ﹤0.01% |
24,383
-32,713
| -57% | -$166K |
|
2094
Vanda Pharmaceuticals
VNDA
$272M
| $123K | ﹤0.01% |
+29,207
| New | +$123K |
|
2095
Lifestance Health
LFST
$2.09B
| $123K | ﹤0.01% |
+15,600
| New | +$123K |
|
2096
Zymeworks
ZYME
$1.14B
| $123K | ﹤0.01% |
11,749
| – | – |
|
2097
Voyager Therapeutics
VYGR
$235M
| $122K | ﹤0.01% |
+14,322
| New | +$122K |
|
|
BCOV
2098
DELISTED
Brightcove, Inc.
BCOV
| $120K | ﹤0.01% |
46,964
+15,753
| +50% | +$40.4K |
|
2099
Rackspace Technology
RXT
$335M
| $120K | ﹤0.01% |
60,208
+1,397
| +2% | +$2.78K |
|
2100
KVH Industries
KVHI
$116M
| $119K | ﹤0.01% |
+22,842
| New | +$119K |
|